Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Kintz Samuel. Officer active across 1 company, notably Enliven Therapeutics, Inc.. Aggregated, 32 disclosures have been recorded. Breakdown: 0 buy · 21 sells. Total volume traded: €2.8m. Activity tracked since 25 September 2023. The latest transaction was filed on 17 October 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Kintz Samuel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12,000 shares@ US$1.120.6% of flowCommon StockSEC:0001415889-24-009220:0
25 of 32 declarations
About Kintz Samuel
Kintz Samuel is a declarant who has made 23 filings in total. In his most recent filings, he sold shares of Enliven Therapeutics, Inc. for a total amount of 1,777,968 euros, with the first transaction recorded on September 26, 2023, and the last scheduled for May 21, 2025. Among his recent filings, he executed a sale of 335,356.07 euros on October 10, 2024, followed by another sale of 304,281.24 euros on October 8, 2024.